The panel will discuss duodenoscopes and their link to drug-resistant infections. The FDA recently released an updated statement urging providers to inform patients of all risks associated with undergoing procedures performed with these scopes, according to the report.
More articles on gastroenterology:
North Texas Endoscope Centers offer free colonoscopy screenings for 50 uninsured people
FDA approves acid reflux device from Somna Therapeutics
Gastroenterology technology company to know: Exalenz Bioscience
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.